-
COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse
11 Apr 2025 19:18 GMT
… in treating uncomplicated vulvovaginal candidiasis (VVC), commonly … the reliance on antifungal medications.”
Kimberly Langdon, … to traditional antifungal treatments. This initial success … upcoming clinical trials and further product development efforts. It …
-
AbbVie Announces European Commission Approval of RINVOQ® for the Treatment of Adults with Giant Cell Arteritis
08 Apr 2025 07:55 GMT
… Germany , and SELECT-GCA trial investigator. "Results … oral/esophageal candidiasis, and cryptococcosis have been … treatment of TB. Patients should be monitored for the development … healthcare professional if medication residue is observed repeatedly …
-
WHO calls for new anti-fungal treatment amid sluggish drug development, growing resistance
03 Apr 2025 15:17 GMT
… of antifungal treatments in clinical and preclinical development. These drugs — Isavuconazole, … trials and approval for public use.
Currently, nine antifungal medications … bloodstream infections or invasive candidiasis reported annually, resulting in …
-
Global Vulvovaginal Candidiasis Treatment Market Outlook 2025-2034: Growth Drivers, Share, And Trends
28 Mar 2025 13:59 GMT
… diseases, development of new drugs specializing in antifungal treatment, and … azole medication, by the Food and Drug Administration FDA. … candidiasis.
How Is The Vulvovaginal Candidiasis Treatment Market Segmented?
The vulvovaginal candidiasis treatment …
-
Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older
25 Mar 2025 22:24 GMT
… trials.
US commercial launch is planned in 2H 2025.
The development … antifungal for the treatment of vulvovaginal candidiasis (VVC) and … BLUJEPA and other antibacterial drugs, BLUJEPA should be … agents, systemic anticholinergic medications, or non-depolarizing …
-
Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older
25 Mar 2025 17:08 GMT
… Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female … two trials.
US commercial launch is planned in 2H 2025.
The development … -class antifungal for the treatment of vulvovaginal candidiasis (VVC) and reduction in …
-
A Novel Supraglottic Suction Device in Mechanically Ventilated Patients: A Randomized Controlled Trial
24 Mar 2025 07:52 GMT
… assignment to the corresponding treatment group. The envelopes … bleeding, lacerations, edema and candidiasis); defects in the functions … the present trial of clinical trial types in … pneumonia: its relevance to developing effective strategies for prevention …
-
World Oral Health Day: Dentist lists 5 common diseases and their treatment options
20 Mar 2025 06:02 GMT
… gum disease.
Oral thrush (Candidiasis): Did you know? … or dentures. Antifungal medications and tablets are prescribed … lumps, and difficulty swallowing. Treatment options include surgery, radiation … features and every unique development in the health sector …
-
Global Surge in Candida Infections Spurs New Treatment Guidelines
11 Mar 2025 06:52 GMT
… as oropharyngeal and vulvovaginal candidiasis, to severe, life-threatening … have developed comprehensive global guidelines for the diagnosis and treatment … particularly for mucosal candidiasis, such as vulvovaginal candidiasis.
Prevention Strategies
Given …
-
The Rising Threat of Fungal Infections and the Urgent Need for New Treatments
11 Mar 2025 00:25 GMT
… . With limited treatment options and rising resistance to existing antifungal drugs, the … fungal infections, which include:
Invasive Candidiasis: A bloodstream infection caused by … : “Over the years, fungi have developed resistance against many of them …